Funded by the NIH HEAL Initiative®
A multisite effectiveness-implementation study will be conducted in four sites to evaluate interventions to improve engagement and retention in MOUD with buprenorphine treatment persons with Opioid Use Disorder (OUD) in urban neighborhoods with high overdose rates. The investigators hypothesize that treatment with the Better Together Integrated Collaborative Community MOUD care model (BT-MOUD) will result in better retention in treatment than standard-of-care MOUD with buprenorphine provided in the hub buprenorphine clinic only (HC-MOUD Only) through 24 weeks following randomization. BT-MOUD provides MOUD with buprenorphine in nonmedical community-based settings via telemedicine from a hub buprenorphine clinic combined with Recovery Guiding, a manual guided coaching developed for this approach, provided onsite in the community organization.
Principal Investigator(s)
Richard Schottenfeld, MD
2041 Georgia Avenue, NW
Washington, DC 20060
United States
Niranjan Karnik, M.D., Ph.D.
1747 West Roosevelt Road
Chicago, IL 60608
United States
Viviana E. Horigian, M.D., M.H.A.
1120 NW 14th Street, Suite 9140
Miami, FL 33136
United States